Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
3,286
Showing 50 of 3,286
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 401 | WATT | Energous Corp | 27/28 | 6 | 56% | +22.2% | +28.6% | +85.0% | -79.6% |
| 402 | MNTR | Mentor Capital, Inc. | 102/154 | 3 | 51% | +22.1% | +14.3% | +150.0% | -60.0% |
| 403 | RYES | Rise Gold Corp. | 92 | 17 | 36% | +22.1% | -16.7% | +233.3% | -78.6% |
| 404 | IOVA | Iovance Biotherapeutics, Inc. | 17 | 8 | 35% | +22.1% | -7.0% | +179.5% | -11.9% |
| 405 | ANGO | Angiodynamics Inc | 15 | 6 | 60% | +22.1% | +33.3% | +58.3% | -14.5% |
| 406 | BAX | Baxter International Inc | 16 | 7 | 81% | +22.0% | +27.4% | +32.9% | -4.0% |
| 407 | MRAI | Marpai, Inc. | 79/81 | 14 | 56% | +22.0% | +59.7% | +161.3% | -129.2% |
| 408 | XFOR | X4 Pharmaceuticals, Inc | 65/66 | 12 | 72% | +22.0% | +25.6% | +89.5% | -73.3% |
| 409 | AQST | Aquestive Therapeutics, Inc. | 16/24 | 9 | 100% | +21.9% | +19.0% | +47.7% | +0.9% |
| 410 | CPRI | Capri Holdings Ltd | 12/15 | 5 | 92% | +21.8% | +25.7% | +30.6% | -15.4% |
| 411 | AHCO | Adapthealth Corp. | 139/192 | 31 | 74% | +21.8% | +23.1% | +49.6% | -47.7% |
| 412 | OCGN | Ocugen, Inc. | 10 | 5 | 80% | +21.8% | +25.2% | +54.2% | -25.0% |
| 413 | MREO | Mereo Biopharma Group PLC | 25 | 6 | 92% | +21.8% | +35.9% | +42.8% | -11.4% |
| 414 | SRPT | Sarepta Therapeutics, Inc. | 43/45 | 11 | 70% | +21.7% | +23.7% | +82.4% | -17.7% |
| 415 | CUK | Carnival PLC | 16/19 | 6 | 69% | +21.6% | +22.3% | +67.4% | -41.4% |
| 416 | AUB | Atlantic Union Bankshares Corp | 10/11 | 5 | 90% | +21.6% | +26.7% | +37.2% | -27.7% |
| 417 | WMG | Warner Music Group Corp. | 51/52 | 15 | 80% | +21.5% | +35.7% | +36.9% | -21.9% |
| 418 | INNV | Innovage Holding Corp. | 24 | 3 | 96% | +21.5% | +20.5% | +54.1% | -52.7% |
| 419 | PRAA | Pra Group Inc | 30 | 10 | 77% | +21.4% | +27.6% | +56.5% | -14.2% |
| 420 | USEG | US Energy Corp | 239/296 | 9 | 76% | +21.4% | +33.1% | +55.2% | -50.2% |
| 421 | AMR | Alpha Metallurgical Resources, Inc. | 363/484 | 18 | 77% | +21.3% | +38.7% | +51.3% | -121.3% |
| 422 | TDOC | Teladoc Health, Inc. | 205/223 | 23 | 79% | +21.3% | +25.0% | +84.7% | -101.7% |
| 423 | MRNA | Moderna, Inc. | 801/808 | 11 | 76% | +21.2% | +28.4% | +75.8% | -93.9% |
| 424 | SGHT | Sight Sciences, Inc. | 87/111 | 13 | 53% | +21.2% | +13.0% | +165.9% | -115.0% |
| 425 | LVWR | Livewire Group, Inc. | 35 | 7 | 89% | +21.2% | +17.9% | +69.2% | -34.1% |
| 426 | XERS | Xeris Biopharma Holdings, Inc. | 22/34 | 13 | 91% | +21.2% | +14.6% | +89.8% | -37.6% |
| 427 | SDST | Stardust Power Inc. | 19/32 | 7 | 79% | +21.2% | +44.0% | +55.6% | -81.8% |
| 428 | DNUT | Krispy Kreme, Inc. | 12/19 | 11 | 83% | +21.2% | +27.2% | +55.6% | -14.7% |
| 429 | JAKK | Jakks Pacific Inc | 89 | 3 | 61% | +21.1% | +16.7% | +159.4% | -53.8% |
| 430 | MRP | Millrose Properties, Inc. | 22/29 | 9 | 68% | +21.1% | +21.7% | +53.6% | -14.2% |
| 431 | NRIM | Northrim Bancorp Inc | 60/66 | 14 | 82% | +21.0% | +17.8% | +52.0% | -17.8% |
| 432 | QNST | Quinstreet, Inc | 35 | 9 | 74% | +21.0% | +32.4% | +83.2% | -55.3% |
| 433 | TLS | Telos Corp | 56/63 | 12 | 77% | +21.0% | +29.1% | +108.0% | -104.7% |
| 434 | BNTC | Benitec Biopharma Inc. | 74/122 | 6 | 76% | +21.0% | +25.8% | +56.1% | -3.6% |
| 435 | ZVIA | Zevia Pbc | 104/113 | 20 | 68% | +20.9% | +37.6% | +251.5% | -107.7% |
| 436 | MAPS | Wm Technology, Inc. | 84/91 | 21 | 75% | +20.8% | +15.9% | +75.5% | -53.5% |
| 437 | CERT | Certara, Inc. | 50 | 10 | 96% | +20.8% | +22.4% | +40.7% | -40.2% |
| 438 | CNMD | Conmed Corp | 72 | 17 | 85% | +20.7% | +27.0% | +38.0% | -20.6% |
| 439 | ATXI | Avenue Therapeutics, Inc. | 12 | 5 | 67% | +20.7% | +66.8% | +89.6% | -88.0% |
| 440 | CCOI | Cogent Communications Holdings, Inc. | 163/171 | 13 | 69% | +20.6% | +14.1% | +65.1% | -47.8% |
| 441 | UAN | Cvr Partners, LP | 156 | 5 | 100% | +20.6% | +19.3% | +44.9% | +9.5% |
| 442 | CHTR | Charter Communications, Inc. /Mo/ | 45/53 | 11 | 80% | +20.6% | +32.6% | +50.1% | -32.1% |
| 443 | PRT | Permrock Royalty Trust | 525 | 3 | 95% | +20.6% | +21.6% | +39.0% | -9.1% |
| 444 | INSG | Inseego Corp. | 13 | 6 | 92% | +20.5% | +21.9% | +46.9% | -34.1% |
| 445 | SPRB | Spruce Biosciences, Inc. | 16 | 4 | 69% | +20.5% | +40.1% | +51.7% | -51.7% |
| 446 | DLPN | Dolphin Entertainment, Inc. | 56/85 | 4 | 71% | +20.5% | +29.5% | +72.4% | -30.8% |
| 447 | ZYME | Zymeworks Inc. | 78/88 | 8 | 72% | +20.4% | +22.5% | +102.2% | -21.3% |
| 448 | RH | Rh | 183/200 | 10 | 80% | +20.4% | +23.1% | +89.9% | -23.8% |
| 449 | JSPR | Jasper Therapeutics, Inc. | 54 | 33 | 31% | +20.2% | -4.3% | +268.9% | -220.4% |
| 450 | RCKT | Rocket Pharmaceuticals, Inc. | 98/113 | 11 | 74% | +20.2% | +21.3% | +69.6% | -89.0% |